Alpine Immune Sciences Shares Rally After Vertex Agrees to Acquire Co.
By Stephen Nakrosis
Shares of Alpine Immune Sciences were trading sharply higher in Wednesday's after-hours market, following news Vertex Pharmaceuticals agreed to acquire the company in a $4.9 billion deal.
Alpine Immune shares were trading 37% higher in the late-trading market, at $64.34, just under the $65 a share offer from Vertex. The shares ended the day's regular trading with a 21% gain, closing at $47.04.
Earlier Wednesday, Alpine Immune shares hit their highest level since 2015 at $47.84 per share.
After the bell, shares of Vertex Pharmaceuticals has lost just over 1%, to trade at $393.24. They ended the day's regular session with a loss of 1.7%, to close at $397.58.
The deal was unanimously approved by the boards of both companies, and is expected to close later this quarter.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
April 10, 2024 17:40 ET (21:40 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing